DNAnexus - Raised $473M Funding from 22 investors - Tracxn

5 days ago · DNAnexus has raised a total funding of $473M over 9 rounds from 22 investors. Investors include TPG, Saints Capital and 20 others. Their latest funding round was of $200M …

$473
OFF

DNAnexus - Raised $473M Funding From 22 Investors - Tracxn

2 weeks from now

5 days ago · DNAnexus has raised a total funding of $473M over 9 rounds from 22 investors. Investors include TPG, Saints Capital and 20 others. Their latest funding round was of $200M …

tracxn.com

$473
OFF

DNAnexus - Company Profile - Tracxn

2 weeks from now

Oct 30, 2024 · DNAnexus - Provider of cloud-based genome informatics & data management platform. Raised a total funding of $473M over 9 rounds from 22 investors. Valued at $600M. …

tracxn.com

$200
OFF

DNANEXUS SECURES $200 MILLION FUNDING LED BY …

2 weeks from now

March 08, 2022 08:45 AM Eastern Standard Time. MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--DNAnexus, Inc., a leading provider of cloud-based biomedical data analysis software serving …

dnanexus.com

$200000000
OFF

Series H - DNAnexus - 2022-03-08 - Crunchbase Funding Round …

2 weeks from now

Mar 8, 2022 · DNAnexus raised $200000000 on 2022-03-08 in Series H. Search Crunchbase. Start Free Trial . ... Edit Investors Section. Number of Investors 6. Number of Partner Investors …

crunchbase.com

$473
OFF

DNAnexus - CoBee Company Profile & Funding Rounds

2 weeks from now

Raised Total: $473M. Social. Facebook Twitter Linkedin Crunchbase Metrics. 457,056Website Global Rank 109,063Website Monthly Traffic Twitter Followers. Description. DNAnexus is a …

cobee.co

$200
OFF

GV-backed DNAnexus Snags $200M To Build Out Genomic Data …

2 weeks from now

Mar 8, 2022 · So far, according to DNAnexus, the platform is used by seven of the world’s top 10 pharmaceutical companies and eight of the 10 biggest diagnostics developers—to single out …

fiercebiotech.com

$200
OFF

DNAnexus Secures $200-Million Funding To Advance Its …

2 weeks from now

DNAnexus provides the technology and products to support this rapidly growing ecosystem and drive critical insights from massive genomic, multi-omic, and clinical datasets. Today, …

drug-dev.com

$473
OFF

LSPR - 209 Competitors And Alternatives In Sep 2024 - Tracxn

2 weeks from now

Sep 9, 2024 · Competitors include Human Longevity, DNAnexus. Toggle navigation. Customers; Offerings; Company. Our Investors; Media & Newsroom ... Funding $473M. Location ...

tracxn.com

$68
OFF

DNAnexus Raises $68m In Latest Funding Sequence

2 weeks from now

Feb 7, 2019 · US-based medical data storage platform developer DNAnexus closed a $68m funding round yesterday featuring GV, a corporate venturing subsidiary of technology …

globalventuring.com

$22
OFF

Elucidata - Raised $22.7M Funding From 8 Investors - Tracxn

2 weeks from now

Elucidata has raised a total funding of $22.7M over 4 rounds from 8 investors. Investors include Eight Roads Ventures, F-Prime Capital and 6 others. Their latest funding round was of $16M …

tracxn.com

$861
OFF

23andMe - Raised $861M Funding From 24 Investors - Tracxn

2 weeks from now

23andMe has raised a total funding of $861M over 14 rounds from 24 investors. Investors include New Enterprise Associates, Johnson & Johnson Innovation – JJDC and 22 others. Their latest …

tracxn.com

FAQs about DNAnexus - Raised $473M Funding from 22 investors - Tracxn Coupon?

How much funding has DNAnexus raised in total?

DNAnexus has raised a total of $472.6M in funding over 9 rounds\. Their latest funding was raised on Mar 8,, 2022 from a Series H round.\ ...

What is DNAnexus's post-money valuation?

According to PrivCo, DNAnexus has a post-money valuation in the range of $1B to $10B as of Mar 8, 2022. DNAnexus has raised a total of $472.6M in funding over 9 rounds. Their latest funding was raised on Mar 8, 2022 from a Series H round. ...

Who are the owners of DNAnexus?

DNAnexus is owned by 18 investors. The most recent investors are Innovatus Capital Partners and Google Ventures. DNAnexus has a post-money valuation in the range of $1B to $10B as of Mar 8,, 2022,, according to PrivCo. ...

When did DNAnexus last close a funding round?

DNAnexus last closed a funding round on Mar 8, 2022 from a Series H round. Other companies that may be considered competitors or alternatives to DNAnexus include Agenus, Dice Therapeutics, and PhaseBio Pharmaceuticals. ...

Who uses DNAnexus?

So far, according to DNAnexus, the platform is used by seven of the world’s top 10 pharmaceutical companies and eight of the 10 biggest diagnostics developers—to single out just a few of its more than 12,000 total users located in four dozen countries across the globe. ...